EUVIMEDEUVIMED entdecken
Crossref

ROS-responsive glucosylated nanodisc prodrug for efficient targeted epilepsy therapy

Yang-Qing He, Peng Guo, Qiu-Lian Hao, Zhenyong Wu, Hai-Hao Han

Chemical Engineering Journal · 2026-06 · 537 · 175927

DOI: 10.1016/j.cej.2026.175927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-06. Verfasst von Yang-Qing He und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Key Technology Research and Development Program of Shandong Province, Taishan Scholar Project of Shandong Province, Chinese Chemical Society.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Key Technology Research and Development Program of Shandong Province
  • Taishan Scholar Project of Shandong Province
  • Chinese Chemical Society
  • National Natural Science Foundation of China

Zitieren

APA

He, Y., Guo, P., Hao, Q., Wu, Z., & Han, H. (2026). ROS-responsive glucosylated nanodisc prodrug for efficient targeted epilepsy therapy. Chemical Engineering Journal, 537, 175927. https://doi.org/10.1016/j.cej.2026.175927

Vancouver

He Y, Guo P, Hao Q, Wu Z, Han H. ROS-responsive glucosylated nanodisc prodrug for efficient targeted epilepsy therapy. Chemical Engineering Journal. 2026;537:175927. doi:10.1016/j.cej.2026.175927

BibTeX
@article{He2026,
  author = {He, Yang-Qing and Guo, Peng and Hao, Qiu-Lian and Wu, Zhenyong and Han, Hai-Hao},
  title = {ROS-responsive glucosylated nanodisc prodrug for efficient targeted epilepsy therapy},
  journal = {Chemical Engineering Journal},
  year = {2026},
  volume = {537},
  pages = {175927},
  doi = {10.1016/j.cej.2026.175927}
}
Kostenlos starten →